Extracellular nucleotides as negative modulators of immunity

被引:94
作者
Di Virgilio, Francesco [1 ]
Boeynaems, Jean-Marie [2 ,3 ,4 ]
Robson, Simon C. [5 ,6 ]
机构
[1] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy
[2] Univ Libre Bruxelles, Sch Med, Brussels, Belgium
[3] Erasme Univ Hosp, Dept Lab Med, Brussels, Belgium
[4] Erasme Univ Hosp, IRIBHM, Brussels, Belgium
[5] Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA USA
[6] Harvard Univ, Boston, MA 02115 USA
关键词
HUMAN DENDRITIC CELLS; ADENOSINE 5'-TRIPHOSPHATE; HUMAN BLOOD; NEUTROPHIL CHEMOTAXIS; SIGNALING MOLECULES; P2; RECEPTORS; ATP; INFLAMMATION; RELEASE; DESENSITIZATION;
D O I
10.1016/j.coph.2009.06.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nucleotides are well known for being the universal currency of intracellular energy transactions, but over the past decade it has become clear that they are also ubiquitous extracellular messengers. In the immune system there is increasing awareness that nucleotides serve multiple roles as stimulants of lymphocyte proliferation, ROS generation, cytokine and chemokine secretion: in one word as pro-inflammatory mediators. However, although often neglected, extracellular nucleotides exert an additional more subtle function as negative modulators of immunity, or as immunedepressants. The more we understand the peculiar biochemical composition of the microenvironment generated at inflammatory sites, the more we appreciate how chronic exposure to low extracellular nucleotide levels affect immunity and inflammation. A deeper understanding of this complex network will no doubt help design more effective therapies for cancer and chronic inflammatory diseases.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 43 条
[1]   Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer [J].
Agteresch, HJ ;
Dagnelie, PC ;
van der Gaast, A ;
Stijnen, T ;
Wilson, JH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04) :321-328
[2]   ATP drives lamina propria TH17 cell differentiation [J].
Atarashi, Koji ;
Nishimura, Junichi ;
Shima, Tatsuichiro ;
Umesaki, Yoshinori ;
Yamamoto, Masahiro ;
Onoue, Masaharu ;
Yagita, Hideo ;
Ishii, Naoto ;
Evans, Richard ;
Honda, Kenya ;
Takeda, Kiyoshi .
NATURE, 2008, 455 (7214) :808-U10
[3]   Differential regulation and relocalization of the platelet P2Y receptors after activation:: A way to avoid loss of hemostatic properties? [J].
Baurand, A ;
Eckly, A ;
Hechler, B ;
Kauffenstein, G ;
Galzi, JL ;
Cazenave, JP ;
Léon, C ;
Gachet, C .
MOLECULAR PHARMACOLOGY, 2005, 67 (03) :721-733
[4]   Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis [J].
Beldi, Guido ;
Wu, Yan ;
Banz, Yara ;
Nowak, Michael ;
Miller, Lindsay ;
Enjyoji, Keiichi ;
Haschemi, Arvand ;
Yegutkin, Gennady G. ;
Candinas, Daniel ;
Exley, Mark ;
Robson, Simon C. .
HEPATOLOGY, 2008, 48 (03) :841-852
[5]   Effects of intestinal microflora and the environment on the development of asthma and allergy [J].
Björkstén, B .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 25 (3-4) :257-270
[6]   Gene expression profiling defines ATP as a key regulator of human dendritic cell functions [J].
Bles, Nathalie ;
Horckmans, Michael ;
Lefort, Anne ;
Libert, Frederic ;
Macours, Pascale ;
El Housni, Hakim ;
Marteau, Frederic ;
Boeynaems, Jean-Marie ;
Communi, Didier .
JOURNAL OF IMMUNOLOGY, 2007, 179 (06) :3550-3558
[7]   Modulation of inflammation by extracellular nucleotides [J].
Boeynaems, Jean-Marie ;
Communi, Didier .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (05) :943-944
[8]   Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation [J].
Bours, M. J. L. ;
Swennen, E. L. R. ;
Di Virgilio, F. ;
Cronstein, B. N. ;
Dagnelie, P. C. .
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (02) :358-404
[9]   Pathophysiology and therapeutic potential of purinergic signaling [J].
Burnstock, G .
PHARMACOLOGICAL REVIEWS, 2006, 58 (01) :58-86
[10]   The past, present and future of purine nucleotides as signalling molecules [J].
Burnstock, G .
NEUROPHARMACOLOGY, 1997, 36 (09) :1127-1139